Elan Drug Technologies Announces Completion of Enrolment in Phase 3
Elan Drug Technologies, a business unit of Elan Corporation, plc announced that Zogenix Inc, its...
Aurobindo Pharma receives FDA tentative approval for Duloxetine Hydrochloride Delayed Release Capsules
Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from...
Merck to Acquire SmartCells, Inc
Merck & Co., Inc., and SmartCells, Inc., announced that they have entered into a definitive...
Amgen Highlights Data to Be Presented at American Society of Hematology Annual Meeting
Amgen announced that it will present data from several key Nplate(R) (romiplostim) studies at the...
Cold Chain Smart Solutions Conference
While cold chain management is becoming an evermore important part of a pharmaceutical firm’s business...
Ranbaxy Launches Donepezil 5MG and 10MG Tablets
Ranbaxy Pharmaceuticals Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL...
Quintiles and London Genetics Alliance T0 Enchance Drug Discovery and Development
Quintiles, the world’s leading bio pharmaceutical services company, and London Genetics, an expert in the...
Vertex Completes New Drug Application for Telaprevir for Hepatitis C
Vertex Pharmaceuticals Incorporated announced that it has completed the submission of a New Drug Application...
Sun Pharma announces FDA tentative approval for generic Cymbalta
Sun Pharmaceutical Industries Ltd. announced US FDA has granted its subsidiary a tentative approval for...
Lilly and Acrux Receive FDA Approval for Axiron Topical Solution CIII
Eli Lilly and Company and Acrux announced that the U.S. FDA has approved Axiron topical...
